EUVIMEDEUVIMED entdecken
Open Access

Association between F2-Isoprostane Metabolites and Weight Change in Older Women: A Longitudinal Analysis

Yingya Zhao, Marina S Nogueira, Qingxia Chen, Qi Dai, Qiuyin Cai, Wanqing Wen, Qing Lan, Nathaniel Rothman, Yu-Tang Gao, Xiao-Ou Shu, Wei Zheng, Ginger L Milne und 1 weitere

Gerontology · 2024 · 70 (2) · 134-142

DOI: 10.1159/000534258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gerontology, online erschienen am 15.11.2023. Verfasst von Yingya Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Cent…. Hauptthemen laut MEDLINE: F2-Isoprostanes, Oxidative Stress. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Theoretically, some metabolic traits may predispose older individuals to weight loss during aging, leading to increased all-cause mortality and many serious health issues. Biomarkers to robustly predict progressive weight loss during aging are, however, lacking. We prospectively assessed if urinary levels of F2-isoprostanes and their peroxisomal β-oxidation metabolite, 2,3-dinor-5,6-dihydro-15-F2t-isoprostane (F2-IsoP-M), were associated with subsequent weight loss in middle-aged and older women.

Methods

Included in the analysis were 2,066 women aged 40–70 years, a subset of a prospective cohort study. F2-isoprostanes (F2-IsoPs) and its β-oxidation metabolite, F2-IsoP-M, were measured in urine using gas chromatography-mass spectrometry. Measurements of anthropometry and exposures to major determinants of body weight were performed at baseline and repeated thrice over 15-year follow-up. The longitudinal associations of F2-IsoP-M and the F2-IsoP-M to its parent compound, F2-IsoP, ratio (MPR) with repeatedly measured weight changes were examined using linear mixed-effect models.

Results

After adjusting for time-varying covariates: energy intake, physical activity, and comorbidity index, among others, levels of F2-IsoP-M and the MPR were both inversely associated with percentage of weight change. Weight in the highest quartile of these two biomarkers was 1.33% (95% CI = −2.41, −0.24) and 1.09% (95% CI = −2.16, −0.02) lower than those in the lowest quartile group, with p for trend of 0.01 and 0.03, respectively. The inverse association was consistently seen across follow-up periods, although appearing stronger with prolonged follow-up. There was no association between the parent compound, F2-IsoPs, and weight change.

Conclusion

This study demonstrates the first piece of evidence to associate F2-IsoP metabolism, peroxisomal β-oxidation, with weight loss in older women. Further investigations into the role of lipid peroxidation and peroxisomal β-oxidation in weight change among older individuals are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

F2-IsoprostanesOxidative StressFemaleHumansMiddle AgedAgedProspective StudiesBiomarkersWeight Loss

Stichwörter der Autor:innen

AgingBeta-oxidationBiomarkerIsoprostaneSarcopeniaWeight loss

Substanzen

F2-IsoprostanesBiomarkers

Autor:innen und Institutionen

  • Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Division of Cancer Epidemiology and Genetics, Occupational and Environmental Epidemiology Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Zhao, Y., Nogueira, M. S., Chen, Q., Dai, Q., Cai, Q., Wen, W., Lan, Q., Rothman, N., Gao, Y. T., Shu, X. O., Zheng, W., Milne, G. L., & Yang, G. (2024). Association between F2-Isoprostane Metabolites and Weight Change in Older Women: A Longitudinal Analysis. Gerontology, 70(2), 134-142. https://doi.org/10.1159/000534258

Vancouver

Zhao Y, Nogueira MS, Chen Q, Dai Q, Cai Q, Wen W, et al. Association between F2-Isoprostane Metabolites and Weight Change in Older Women: A Longitudinal Analysis. Gerontology. 2024;70(2):134-142. doi:10.1159/000534258

BibTeX
@article{Zhao2024,
  author = {Zhao, Yingya and Nogueira, Marina S and Chen, Qingxia and Dai, Qi and Cai, Qiuyin and Wen, Wanqing and Lan, Qing and Rothman, Nathaniel and Gao, Yu-Tang and Shu, Xiao-Ou and Zheng, Wei and Milne, Ginger L and Yang, Gong},
  title = {Association between F2-Isoprostane Metabolites and Weight Change in Older Women: A Longitudinal Analysis},
  journal = {Gerontology},
  year = {2024},
  volume = {70},
  number = {2},
  pages = {134--142},
  doi = {10.1159/000534258}
}
Kostenlos starten →